| Pharmaceutical studies and practices | Lifetime | 2 | US 2 | 99.91 |
| Schizophrenia research and treatment | Lifetime | 4 | US 2 | 99.97 |
| Bipolar Disorder and Treatment | Lifetime | 5 | US 3 | 99.94 |
| Mental Health and Psychiatry | Lifetime | 10 | US 5 | 99.81 |
| Treatment of Major Depression | Lifetime | 31 | US 18 | 99.67 |
| Tryptophan and brain disorders | Lifetime | 60 | US 28 | 99.58 |
| Attention Deficit Hyperactivity Disorder | Lifetime | 61 | US 39 | 99.35 |
| Diabetes Treatment and Management | Lifetime | 115 | US 52 | 99.48 |
| Electroconvulsive Therapy Studies | Lifetime | 23 | US 12 | 99.45 |
| Diet and metabolism studies | Lifetime | 287 | US 121 | 99.37 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 46 | US 34 | 99.35 |
| Adolescent and Pediatric Healthcare | Lifetime | 80 | US 43 | 98.91 |
| Mental Health Treatment and Access | Lifetime | 152 | US 66 | 99.18 |
| Child and Adolescent Psychosocial and Emotional Development | Lifetime | 364 | US 238 | 99.19 |
| Cardiac Health and Mental Health | Lifetime | 174 | US 105 | 98.49 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 872 | US 395 | 98.12 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 532 | US 197 | 98.28 |
| Mental Health Research Topics | Lifetime | 460 | US 260 | 97.85 |
| Child Nutrition and Feeding Issues | Lifetime | 499 | US 257 | 96.74 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 558 | US 195 | 96.31 |
| Eating Disorders and Behaviors | Lifetime | 973 | US 441 | 95.37 |
| Psychiatric care and mental health services | Lifetime | 416 | US 105 | 94.45 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 858 | US 372 | 93.37 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 214 | US 80 | 91.06 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 570 | US 198 | 61.82 |
| Schizophrenia research and treatment | 2021-2025 | 1 | US 1 | 99.98 |
| Bipolar Disorder and Treatment | 2021-2025 | 1 | US 1 | 99.95 |
| Mental Health and Psychiatry | 2021-2025 | 1 | US 1 | 99.91 |
| Mental Health Treatment and Access | 2021-2025 | 5 | US 2 | 99.78 |
| Pharmaceutical studies and practices | 2021-2025 | 4 | US 3 | 99.47 |
| Tryptophan and brain disorders | 2021-2025 | 10 | US 1 | 99.64 |
| Treatment of Major Depression | 2021-2025 | 4 | US 1 | 99.79 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 6 | US 3 | 99.46 |
| Receptor Mechanisms and Signaling | 2021-2025 | 12 | US 4 | 99.03 |
| Mental Health Research Topics | 2021-2025 | 37 | US 13 | 98.87 |
| Child and Adolescent Psychosocial and Emotional Development | 2021-2025 | 87 | US 34 | 98.56 |
| Adolescent and Pediatric Healthcare | 2021-2025 | 37 | US 11 | 97.17 |
| Attention Deficit Hyperactivity Disorder | 2021-2025 | 39 | US 8 | 97.62 |
| Electroconvulsive Therapy Studies | 2021-2025 | 16 | US 3 | 97.00 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 40 | US 12 | 97.31 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 356 | US 121 | 96.61 |
| Cardiac Health and Mental Health | 2021-2025 | 115 | US 41 | 95.64 |
| Child Nutrition and Feeding Issues | 2021-2025 | 117 | US 43 | 94.86 |
| Diet and metabolism studies | 2021-2025 | 566 | US 166 | 94.81 |
| Eating Disorders and Behaviors | 2021-2025 | 207 | US 81 | 94.88 |
| Autism Spectrum Disorder Research | 2021-2025 | 597 | US 256 | 91.33 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 699 | US 251 | 88.62 |
| Digital Mental Health Interventions | 2021-2025 | 978 | US 286 | 82.35 |
| Electrolyte and hormonal disorders | 2021-2025 | 700 | US 178 | 65.63 |
| Psychiatric care and mental health services | 2021-2025 | 660 | US 66 | 57.90 |
| Stuttering Research and Treatment | 2021-2025 | 717 | US 256 | 23.89 |
